参考文献/References:
[1] Sadeghi M,Keshavarz-Fathi M,BaracosV,et al.Cancer cachexia:Diagnosis,assessment,and treatment[J].Crit Rev Oncol Hematol,2018,127(7):91-104.
[2] 段振东.中晚期胃癌患者体质量指数与预后的相关性及中药对胃癌患者生存质量影响的临床研究[D].天津:天津中医药大学,2020.
[3] Lee W S,Lee J J,Liao A T,et al.Association between weight change during initial chemotherapy and clinical outcome in dogs with multicentric lymphoma[J].Vet Comp Oncol,2021,19(1):53-60.
[4] Morita Y,Sakaguchi T,Kitajima R,et al.Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer[J].BMC Cancer,2019,19(1):416.
[5] Argilés J M,Busquets S,Stemmler B,et al.Cancer cache xia:understanding the molecular basis[J].Nat Rev Cancer, 2014,14(11):754-762.
[6] Mondello P,Mian M,Aloisi C,et al.Cancer cachexia syndrome:pathogenesis,diagnosis,and new therapeutic options[J].Nutr Cancer,2015,67(1):12-26.
[7] Baracos V E,Martin L,Korc M,et al.Cancer-associated cachexia[J].Nat Rev Dis Primers,2018,4(1):17105.
[8] Anderson L J,Albrecht E D,Garcia J M.Erratum to:update on management of cancer-related cachexia[J].Curr Oncol Rep,2017,19(3):22.
[9] Zhang W L,Li N,Shen Q,et al.Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I[J].Acta PharmacolSin,2020,41(2):237-248.
[10] 谢丽霞.基于ERK/MAPK通路探讨芪药鸡金粥对化疗后大鼠胃肠黏膜机械屏障损伤的保护作用[D].福州:福建中医药大学,2015.
[11] 李天苗,李爽,米硕,等.健脾益气方治疗肺脾气虚型非小细胞肺癌患者化疗后癌因性疲乏的随机对照研究[J].辽宁中医杂志,2021,48(8):126-129.
[12] Touchefeu Y,Montassier E,Nieman K,et al.Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications[J].Aliment Pharmacol Ther,2014,40(5):409-421.
[13] Wu J,Gan Y,Li M,et al.Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2/MyD88/NF-kB pathway and regulation of microbiota[J].Biomed Pharmacother,2020,124(8):109883.
[14] 邵铁娟,李海昌,谢志军,等.基于脾主运化理论探讨脾虚湿困与肠道菌群紊乱的关系[J].中华中医药杂志,2014,29(12):3762-3765.
[15] 陈彬,梁芳,袁旭,等.健脾解毒方加减对脾气亏虚证晚期结直肠癌化疗患者肠道菌群及免疫功能的影响[J].中医杂志,2020,61(5):423-427.
[16] 马丽娟,王锡恩,张静,等.益气健脾方对宫颈癌同步放化疗脾虚证候及免疫状态的影响[J].中华中医药学刊,2020,38(10):236-239.
[17] 段永强,成映霞,梁玉杰,等.益气健脾中药对脾虚大鼠骨骼肌组织中Ca2+/CaMKⅡ通路关键分子的干预作用[J].中药材,2015,38(3):562-566.
[18] Xiong B,Qian H.Effects of Sijunzi decoction and Yupingfeng powder on expression of janus kinase-signal transducer and activator of transcription signal pathway in the brain of spleen-deficiency model rats[J].J Tradit Chin Med,2013, 33(1):78-84.
[19] Cario E,Gerken G,Podolsky D K.Toll-like receptor 2 con-trols mucosal inflammation by regulating epithelial barrier function[J].Gastroenterology,2007,132(4):1359-1374.
[20] Thorpe D W,Stringer A M,Gibson R J.Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors[J].Exp Biol Med(Maywood), 2013,238(1):1-6.
[21] 胡莹.益气健脾化积方对GC化疗的增效作用及对NF-κB信号通路调控的影响[D].南京:南京中医药大学,2019.
[22] Garlanda C,Dinarello C A, Mantovani A.The interleukin-1 family: back to the future[J].Immunity,2013,39(6):1003-1018.
[23] Scheller J,Chalaris A,Schmidt-Arras D,et al.The pro-and anti-inflammatory properties of the cytokine interleukin-6[J].Biochim Biophys Acta,2011,1813(5):878-888.
[24] 汪耔璇.补中益气汤联合FOLFIRI化疗方案治疗晚期结直肠癌的临床研究[D].南京:南京中医药大学,2020.
[25] 董飞燕.补中益气汤联合肠内营养支持对胃癌转化化疗患者营养状况的临床研究[D].杭州:浙江中医药大学,2019.
[26] 梁建斌,刘刚.健脾燥湿汤在脾虚湿盛型大肠癌术后化疗患者中的应用[J].中国肛肠病杂志,2018,38(3):12-14.
[27] 张素芳,凌昌全,李柏,等.四生汤对脾虚证小鼠免疫功能和抗应激能力的影响(英文)[J].中西医结合学报,2012,10(12):1465-1469.